Watchlist Price Alert

Intercept Pharmaceuticals... (ICPT)

NASDAQ: ICPT · Real-Time Price · USD

19.00

0.04 (0.21%)

At close: Nov 07, 2023, 9:00 PM

Intercept Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	50.52M	84.71M	58.15M	70.06M	436.16M	414.92M	689.38M
Short-Term Investments	435.05M	334.98M	411.52M	582.57M	392.91M	344.9M	645.71M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	12.6M	15.23M	84.67M	15.12M	16.33M	19.86M	20.09M
Receivables	26.86M	47.62M	41.55M	38.04M	25.69M	18.57M	12.34M
Inventory	6.46M	8.62M	-68.57M	8.46M	7.11M	1.00	2.28M
Other Current Assets	22.36M	25.29M	27.02M	25.92M	20.57M	16.89M	9.35M
Total Current Assets	540.13M	502.29M	477.17M	721.32M	482.43M	448.31M	707.87M
Property-Plant & Equipment	987K	9.5M	18.65M	18.45M	10.41M	16.18M	11.29M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.58M	24.73M	103.32M	33.57M	26.74M	36.04M	31.39M
Total Assets	553.71M	527.02M	580.49M	754.89M	509.17M	484.35M	739.25M
Account Payables	14.23M	18.13M	24.59M	18.98M	11.77M	6.96M	6.72M
Deferred Revenue	n/a	136.69M	138.29M	130.53M	1.62M	1.78M	5.69M
Short-Term Debt	109.57M	3.04M	7.25M	6.46M	82.49M	n/a	n/a
Other Current Liabilities	106.27M	8.95M	8.94M	6.04M	18.33M	95.29M	66.1M
Total Current Liabilities	230.08M	166.82M	179.08M	162M	114.2M	104.03M	78.51M
Long-Term Debt	223.1M	544.17M	568.27M	532.08M	371.25M	355.68M	341.36M
Other Long-Term Liabilities	7.45M	n/a	n/a	9.25M	3.77M	5.58M	-5.69M
Total Long-Term Liabilities	230.56M	544.17M	568.27M	541.33M	375.83M	363.93M	345.81M
Total Liabilities	460.63M	710.99M	747.34M	703.33M	490.04M	467.96M	424.32M
Total Debt	332.67M	547.21M	575.51M	538.53M	371.25M	355.68M	341.36M
Common Stock	42K	30K	33K	33K	30K	25K	25K
Retained Earnings	-2.14B	-2.49B	-2.4B	-2.12B	-1.78B	-1.47B	-1.11B
Comprehensive Income	-8.26M	-2.87M	-2.48M	-1.14M	-2.26M	-786K	-2.8M
Shareholders Equity	93.08M	-183.96M	-166.85M	51.56M	19.13M	16.39M	314.93M
Total Investments	435.05M	334.98M	411.52M	582.57M	392.91M	344.9M	645.71M